At the beginning of the year, the enthusiasm of listed pharmaceutical companies to buy back was still high, and many companies issued repurchase plans
.
Among them, a number of companies have invested heavily in share
buybacks.
On January 9, Guizhou Bailing announced that it intends to repurchase the company's shares for 100 million to 200 million yuan for the later implementation of equity incentives or employee stock ownership plans
.
Specifically, the number of shares repurchased is expected to range from 7.
22 million shares (inclusive) to 14.
44 million shares (inclusive), accounting for 0.
51% to 1.
02%
of the company's total share capital as of January 6, 2023.
The repurchase price does not exceed 13.
85 yuan per share
.
As of September 30, 2022, Guizhou Bailing had total assets of about 6.
650 billion yuan, net assets of about 4.
024 billion yuan, and an asset-liability ratio of 39.
16%.
Based on the upper limit of the repurchase amount of 200 million yuan, it accounts for about 3.
01% of total assets and 4.
97%
of net assets.
Guizhou Bailing believes that this repurchase will not have a significant impact
on the company's operations, finances and future development.
Beikang announced on January 9 that it intends to spend 47,700 yuan to 15,960,400 yuan to repurchase the company's shares, the number of repurchased shares is not less than 1,500 shares, no more than 501,900 shares, and the price of repurchased shares does not exceed 31.
8 yuan per share
.
According to the number of proposed repurchases and the upper limit of the proposed repurchase price, the estimated total repurchase funds range from 47,700 to 15,960,400, and the source of funds is own funds
.
According to the data, BYIKANG is an intelligent rehabilitation equipment manufacturer
integrating R&D, production, sales and service.
In addition, Langsheng Pharmaceutical also announced that it spent HK$45,000 to repurchase 30,000 shares on January 9, 2023 at a repurchase price of HK$
1.
5 per share.
It is worth noting that Longson Pharma repurchases are very frequent, as previously announced, on January 5, 2023, the company repurchased 150,000 shares at a cost of HK $225,000, on January 4, the company spent HK $375,000 to buy back 250,000 shares at a repurchase price of HK $1.
5 per share, and on December 30, 2022, it spent HK $159,000 to buy back 106,000 shares at a repurchase price of HK $1.
5 per share.
.
.
In fact, it has always been common for companies or executives to buy back their own shares, and last year, listed pharmaceutical and biological companies ushered in a wave of
buybacks.
Wind data shows that as of December 30, 2022, a total of 1,156 A-share companies carried out share buybacks
during the year.
Among them, there are 131 pharmaceutical and biological listed companies, accounting for 11.
3%, ranking first
among 28 Shenwan first-class industries.
The amount involved in the repurchase exceeded 12.
41 billion yuan, and the number of repurchases reached 228.
The top 5 companies with higher amounts are Hengrui Pharmaceutical, Mindray Medical, Kailaiying, Yunnan Baiyao and Health Yuan
.
In terms of repurchase amount, the amount amounted to RMB1.
06 billion, RMB1.
0 billion, RMB810 million, RMB710 million and RMB600 million respectively.
The number of repurchases was 29.
01 million shares, 3.
25 million shares, 5.
297 million shares, 12.
6 million shares and 51.
308 million shares
, respectively.
On the whole, equity incentive cancellation, implementation of equity incentives, employee stock ownership plans, market value management, profit compensation, etc.
are the main uses
of pharmaceutical companies for repurchase.
However, analysts believe that although buybacks help boost investor confidence in the company, in the long run, in the end, fundamentals will play a role in improving stock prices, and pharmaceutical companies should continue to improve their "hard power"
.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)]; 
